H.R. 2820: Stem Cell Therapeutic and Research Reauthorization Act of 2015

This was a vote to pass H.R. 2820 in the House. The federal budget process occurs in two stages: appropriations, which set overall spending limits by agency or program, and authorizations, which direct how federal funds should (or should not) be used. Appropriation and authorization provisions are typically made for single fiscal years. A reauthorization bill like this one renews the authorizations of an expiring law. This vote was taken under a House procedure called “suspension of the rules” which is typically used to pass non-controversial bills. Votes under suspension require a 2/3rds majority. A failed vote under suspension can be taken again.

Congress
114th Congress
Date
Dec 16, 2015
Chamber
House
Number
#695
Question:
On Motion to Suspend the Rules and concur in the Senate Amendment in the House
Result:
Passed

Key: R Yea D Yea
Seat position based on our ideology score.
This is a cartogram. Each hexagon represents one congressional district.
Totals     Republican     Democrat
  Yea 421
 
 
97%
240 181
  Nay 0
 
 
0%
0 0
Not Voting 12
 
 
3%
5 7
Required: 2/3 source: house.gov

Vote Details

Notes: The Speaker’s Vote? “Aye” or “Yea”?
Download as CSV | XML | JSON

Statistically Notable Votes

Statistically notable votes are the votes that are most surprising, or least predictable, given how other members of each voter’s party voted and other factors.

All Votes